BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26796601)

  • 1. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
    Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
    Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy.
    Sabater S; Arenas M; Berenguer R; Machin-Hamalainen S; Andres I; Sevillano MM; Jimenez-Jimenez E; Martos A; Lopez-Honrubia V; Fernandez-Lopez J
    Brachytherapy; 2015; 14(4):458-63. PubMed ID: 25900391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position.
    Iatì G; Pontoriero A; Mondello S; Brogna A; Di Pasquale A; Ielo I; Potami A; Messina G; De Renzis C; Pergolizzi S
    Brachytherapy; 2014; 13(6):568-71. PubMed ID: 24986362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
    Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
    Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.
    Sabater S; Andres I; Sevillano M; Berenguer R; Machin-Hamalainen S; Arenas M
    Brachytherapy; 2014; 13(4):343-51. PubMed ID: 24388615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the organs at risk be contoured in vaginal cuff brachytherapy?
    Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
    Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
    Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
    J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal contrast increases rectal dose during vaginal cuff brachytherapy.
    Sabater S; Andres I; Jimenez-Jimenez E; Berenguer R; Sevillano M; Lopez-Honrubia V; Rovirosa A; Sanchez-Prieto R; Arenas M
    Brachytherapy; 2016; 15(1):35-9. PubMed ID: 26612699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer.
    Caon J; Holloway C; Dubash R; Yuen C; Aquino-Parsons C
    Brachytherapy; 2014; 13(1):94-9. PubMed ID: 24269147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal packing volume impact on dose parameters during radiography and computed tomography based postoperative brachytherapy of cervical carcinoma.
    Tomasevic A; Plesinac-Karapandzic V; Stojanovic-Rundic S; Vuckovic S; Stevanovic J; Gavrilovic D; Nadrljanski M
    J BUON; 2017; 22(6):1509-1516. PubMed ID: 29332346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
    Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
    J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of rectal/bladder filling and applicator positioning on in vivo rectal dosimetry in vaginal cuff brachytherapy using an enhanced therapy setting.
    Bergau PFL; Schirmer MA; Leha A; Leu M; Emons G; Hess CF; Hille A
    Brachytherapy; 2020; 19(2):168-175. PubMed ID: 31883803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?
    Zhou J; Prisciandaro J; Lee C; Schipper M; Eisbruch A; Jolly S
    Pract Radiat Oncol; 2014; 4(1):20-6. PubMed ID: 24621419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk.
    Glaser SM; Kim H; Beriwal S
    Brachytherapy; 2015; 14(6):913-8. PubMed ID: 26412618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.